Profound Medical (PROF) Competitors $5.50 +0.19 (+3.58%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$5.48 -0.01 (-0.27%) As of 10/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. SIBN, BFLY, BVS, ZIMV, AVNS, CBLL, KIDS, SMLR, TMCI, and DCTHShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors SiBone Butterfly Network Bioventus ZimVie AVANOS MEDICAL CeriBell OrthoPediatrics Semler Scientific Treace Medical Concepts Delcath Systems Profound Medical (NASDAQ:PROF) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Do insiders & institutionals hold more shares of PROF or SIBN? 47.9% of Profound Medical shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer PROF or SIBN? Profound Medical currently has a consensus price target of $11.00, indicating a potential upside of 100.00%. SiBone has a consensus price target of $23.00, indicating a potential upside of 48.48%. Given Profound Medical's higher probable upside, equities research analysts clearly believe Profound Medical is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00SiBone 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is PROF or SIBN more profitable? SiBone has a net margin of -12.83% compared to Profound Medical's net margin of -343.97%. SiBone's return on equity of -14.20% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-343.97% -89.74% -73.06% SiBone -12.83%-14.20%-10.38% Which has more risk & volatility, PROF or SIBN? Profound Medical has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, SiBone has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Does the media favor PROF or SIBN? In the previous week, SiBone had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for SiBone and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.95 equaled SiBone'saverage media sentiment score. Company Overall Sentiment Profound Medical Positive SiBone Positive Which has stronger earnings and valuation, PROF or SIBN? Profound Medical has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M15.55-$27.82M-$1.46-3.77SiBone$185.26M3.61-$30.91M-$0.56-27.66 SummarySiBone beats Profound Medical on 11 of the 15 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$160.21M$2.97B$6.24B$10.65BDividend YieldN/A57.75%5.71%4.82%P/E Ratio-3.7726.3230.6130.44Price / Sales15.55782.63596.73191.77Price / CashN/A168.3237.0161.44Price / Book2.745.6512.036.60Net Income-$27.82M$33.06M$3.32B$276.82M7 Day Performance-0.54%3.16%1.89%2.55%1 Month Performance7.42%8.14%7.71%3.76%1 Year Performance-24.76%-2.49%56.33%33.04% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.5591 of 5 stars$5.50+3.6%$11.00+100.0%-23.7%$160.21M$10.68M-3.77150SIBNSiBone3.6991 of 5 stars$14.94+1.1%$23.67+58.4%+22.8%$637.62M$167.18M-26.68350BFLYButterfly Network2.656 of 5 stars$2.30+0.7%$3.00+30.7%+26.4%$573.97M$82.06M-8.20460Analyst ForecastGap UpBVSBioventus0.8707 of 5 stars$6.57+0.9%N/AN/A$538.24M$573.28M13.021,200News CoverageAnalyst ForecastZIMVZimVie0.6177 of 5 stars$18.97+0.1%$17.75-6.4%+34.2%$534.88M$449.75M-27.101,770Upcoming EarningsAVNSAVANOS MEDICAL2.4939 of 5 stars$10.86+1.5%N/A-46.9%$496.51M$687.80M-1.082,227News CoverageUpcoming EarningsCBLLCeriBell2.505 of 5 stars$11.98+0.3%$32.14+168.3%N/A$438.13M$65.44M-4.01N/ANews CoverageAnalyst ForecastKIDSOrthoPediatrics4.5089 of 5 stars$17.51+7.4%$26.29+50.1%-33.5%$408.70M$204.73M-9.78200Upcoming EarningsSMLRSemler Scientific3.5242 of 5 stars$26.33-1.8%$74.25+182.0%-13.4%$405.81M$56.29M10.84120Trending NewsTMCITreace Medical Concepts2.1473 of 5 stars$6.00+2.0%$9.83+63.9%+39.4%$371.46M$209.36M-7.59250News CoverageAnalyst ForecastDCTHDelcath Systems2.7087 of 5 stars$11.35+8.5%$24.50+115.9%-3.9%$365.90M$37.21M227.0060News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies SIBN Competitors BFLY Competitors BVS Competitors ZIMV Competitors AVNS Competitors CBLL Competitors KIDS Competitors SMLR Competitors TMCI Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
